Skip to main content

Table 1 Clinical correlation of hedgehog pathway with demographic and pathological variables in Pakistani breast cancer cohort

From: Involvement of hedgehog pathway in early onset, aggressive molecular subtypes and metastatic potential of breast cancer

Variable

Total

Meanā€‰Ā±ā€‰SD

SHH

p-value

DHH

p-value

IHH

p-value

PTCH

p-value

SMO

p-value

GLI-1

p-value

Tumour

150

4.4Ā Ā±Ā 3.3

< 0.0001

4.7Ā Ā±Ā 3.5

< 0.0001

0.04Ā Ā±Ā 0.2

< 0.0001

3.4Ā Ā±Ā 3.1

< 0.0001

1.4Ā Ā±Ā 2.1

0.61

3.8Ā Ā±Ā 2.5

< 0.0001

Control

150

1.0Ā Ā±Ā 0.9

1.0Ā Ā±Ā 1.4

1.0Ā Ā±Ā 1.1

1.0Ā Ā±Ā 1.0

1.0Ā Ā±Ā 1.3

1.0Ā Ā±Ā 0.8

Disease onset age

ā€ƒAgeā€‰ā‰¤ā€‰45Ā years

76

5.6Ā Ā±Ā 3.9

0.03

5.5Ā Ā±Ā 4.2

0.04

0.2Ā Ā±Ā 0.8

0.65

3.2Ā Ā±Ā 3.1

0.26

1.9Ā Ā±Ā 2.2

0.03

6.3Ā Ā±Ā 4.5

0.03

ā€ƒAgeā€‰ā‰„ā€‰45Ā years

74

4.2Ā Ā±Ā 3.3

3.9Ā Ā±Ā 2.9

0.04Ā Ā±Ā 0.2

3.6Ā Ā±Ā 3.0

1.2Ā Ā±Ā 1.8

4.2Ā Ā±Ā 2.7

Menopausal status

ā€ƒPre-Menopausal

80

6.8Ā Ā±Ā 4.8

0.0065

5.6Ā Ā±Ā 3.9

0.01

0.23Ā Ā±Ā 0.8

0.45

0.2Ā Ā±Ā 0.8

< 0.0001

2.8Ā Ā±Ā 3.6

0.12

7.9Ā Ā±Ā 4.3

< 0.0001

ā€ƒPost-Menopausal

70

4.5Ā Ā±Ā 3.5

3.9Ā Ā±Ā 3.0

0.05Ā Ā±Ā 0.2

3.9Ā Ā±Ā 3.3

2.1Ā Ā±Ā 3.1

3.9Ā Ā±Ā 2.5

Laterality

ā€ƒRight

75

4.2Ā Ā±Ā 2.8

0.01

5.8Ā Ā±Ā 4.0

0.001

0.2Ā Ā±Ā 0.8

0.13

3.4Ā Ā±Ā 2.9

0.97

2.5Ā Ā±Ā 2.9

0.26

4.5Ā Ā±Ā 2.9

0.02

ā€ƒLeft

75

6.1Ā Ā±Ā 4.1

3.8Ā Ā±Ā 3.0

0.1Ā Ā±Ā 0.4

3.4Ā Ā±Ā 3.2

2.1Ā Ā±Ā 3.1

6.4Ā Ā±Ā 4.5

Grade-wise distribution

ā€ƒGrade I

14

3.5Ā Ā±Ā 2.7

0.0001

3.4Ā Ā±Ā 2.4

0.48

0.2Ā Ā±Ā 0.9

0.2

2.9Ā Ā±Ā 2.9

0.68

2.4Ā Ā±Ā 3.5

0.11

2.8Ā Ā±Ā 1.9

0.01

ā€ƒGrade II

90

5.0Ā Ā±Ā 3.8

4.9Ā Ā±Ā 3.7

0.2Ā Ā±Ā 0.6

3.4Ā Ā±Ā 3.2

2.6Ā Ā±Ā 3.2

3.2Ā Ā±Ā 1.8

ā€ƒGrade III

46

9.4Ā Ā±Ā 6.5

4.9Ā Ā±Ā 3.6

0.09Ā Ā±Ā 0.3

3.6Ā Ā±Ā 3.2

2.1Ā Ā±Ā 3.6

5.6Ā Ā±Ā 4.3

Stage-wise distribution

ā€ƒStage I

34

4.2Ā Ā±Ā 3.3

< 0.0001

6.2Ā Ā±Ā 3.6

< 0.0001

0.1Ā Ā±Ā 0.5

0.03

3Ā Ā±Ā 2.8

0.35

2.6Ā Ā±Ā 3.3

0.09

6.7Ā Ā±Ā 3.9

0.005

ā€ƒStage II

68

7.1Ā Ā±Ā 4.1

8.3Ā Ā±Ā 3.7

0.2Ā Ā±Ā 0.7

3.3Ā Ā±Ā 3.2

2.3Ā Ā±Ā 2.7

7.2Ā Ā±Ā 3.6

ā€ƒStage III

43

8.7Ā Ā±Ā 3.9

8.6Ā Ā±Ā 3.8

0.1Ā Ā±Ā 0.2

3.6Ā Ā±Ā 2.9

1.3Ā Ā±Ā 1.7

7.9Ā Ā±Ā 3.8

ā€ƒStage IV

5

14.6Ā Ā±Ā 2.9

17Ā Ā±Ā 2.2

0.06Ā Ā±Ā 0.1

4.9Ā Ā±Ā 2.8

2.3Ā Ā±Ā 1.9

14.5Ā Ā±Ā 3

Nodal Involvement

ā€ƒN0 (none)

48

4.3Ā Ā±Ā 3.2

< 0.0001

3.3Ā Ā±Ā 2.8

0.01

0.2Ā Ā±Ā 0.5

0.02

2.9Ā Ā±Ā 3

0.34

2.6Ā Ā±Ā 3.2

0.92

4.1Ā Ā±Ā 2.7

0.003

ā€ƒN1(lymph nodeā€‰<ā€‰4)

78

6.1Ā Ā±Ā 4.1

5.8Ā Ā±Ā 4.2

0.2Ā Ā±Ā 0.7

3.6Ā Ā±Ā 3.2

2.3Ā Ā±Ā 3.3

5.9Ā Ā±Ā 3.6

ā€ƒN2(lymph nodeā€‰>ā€‰4)

24

8.2Ā Ā±Ā 3.7

6.5Ā Ā±Ā 4.4

0.006Ā Ā±Ā 0

3.6Ā Ā±Ā 2.8

2.7Ā Ā±Ā 3.9

6.6Ā Ā±Ā 3.9

Distant Metastasis

ā€ƒM0

145

4.4Ā Ā±Ā 3.4

0.0003

4.5Ā Ā±Ā 3.4

0.0002

0.14Ā Ā±Ā 0.6

0.09

3.3Ā Ā±Ā 3.0

0.12

2.4Ā Ā±Ā 3.4

0.34

3.8Ā Ā±Ā 2.5

0.0002

ā€ƒM1

5

14.6Ā Ā±Ā 2.9

17Ā Ā±Ā 2.2

0.06Ā Ā±Ā 0.1

4.9Ā Ā±Ā 2.8

2.3Ā Ā±Ā 1.8

14.5Ā Ā±Ā 3

Molecular subtypes

ā€ƒHER-2

21

2.7Ā Ā±Ā 2.4

< 0.0001

2.2Ā Ā±Ā 1.1

< 0.0001

0.03Ā Ā±Ā 0.1

0.73

4.3Ā Ā±Ā 4.5

0.04

2.5Ā Ā±Ā 3

0.63

3.7Ā Ā±Ā 2.1

0.0007

ā€ƒLuminal A

23

5.3Ā Ā±Ā 2.8

1.9Ā Ā±Ā 1.6

0.06Ā Ā±Ā 0.2

2.1Ā Ā±Ā 1.9

1.9Ā Ā±Ā 2.7

2.7Ā Ā±Ā 1.6

ā€ƒLuminal B

79

6.7Ā Ā±Ā 2.7

4.9Ā Ā±Ā 3.5

0.1Ā Ā±Ā 0.4

3.7Ā Ā±Ā 3

2.6Ā Ā±Ā 3.4

5.2Ā Ā±Ā 2.9

ā€ƒTriple Negative

27

5.9Ā Ā±Ā 3.2

2.9Ā Ā±Ā 2.6

0.3Ā Ā±Ā 0.8

4.1Ā Ā±Ā 3.8

1.8Ā Ā±Ā 2.8

3.8Ā Ā±Ā 2.5